Log in
网页Log in
Home - Vyne
网页Vyne is a revenue acceleration and interoperability platform company specializing in intelligently connecting dental practices, patients, and payers in the dental sector, and automating patient access for large hospitals and health systems in the medical sector.
Dental Revenue Cycle Management and Billing Solutions | Vyne …
网页Vyne Dental’s® unified end-to-end electronic platform promotes efficient transactions between payers and providers. We serve insurance companies, dental plans, self-insured employers, and third-party administrators by enhancing dental claims and billing processes through electronic information exchange. Over 800 connections and growing.
VYNE Therapeutics – Rooted in Innovation
网页VYNE Therapeutics ® is working to solve some of today’s most difficult therapeutic challenges. With every problem we take on, our approach is the same: question traditional assumptions and find a better solution. Learn More.
VYNE Therapeutics Inc. (VYNE) Stock Price, News, Quote
网页VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary and therapeutics for the treatment of immuno-inflammatory conditions.
VYNE Therapeutics Announces FDA Clearance of IND
网页2024年5月6日 · VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET Inhibitor. In preclinical studies, VYN202 achieved consistent reductions in pro-inflammatory...
Vyne Therapeutics Inc (VYNE) Stock Price & News - Google
网页Get the latest Vyne Therapeutics Inc (VYNE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions ...
VYNE Therapeutics Inc. Common Stock (VYNE) - Nasdaq
网页Discover real-time VYNE Therapeutics Inc. Common Stock (VYNE) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
VYNE Therapeutics Announces Positive Results from Phase 1a …
网页BRIDGEWATER, N.J., Feb. 15, 2023 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced positive results from the …
VYNE Therapeutics Announces Positive Biomarker Data from …
网页2024年1月10日 · Exploratory data from the 1.0% and 2.0% cohorts showed that VYN201 treatment demonstrated biological activity and a positive effect on certain key biomarkers relevant to vitiligo disease severity...